Evening Chronicle (Newcastle, England), July 8, 2009
THE North East’s Regional Neurosciences Service currently at the NGH is one of the top units in the UK.
The many outstanding experts who work here provide a comprehensive range of specialist tests, assessments and often lifesaving procedures for all types of neurological conditions involving the brain and nervous system.
These include brain tumours, epilepsy, head injuries, multiple sclerosis, stroke and conditions affecting the spinal cord and back.
This major treatment centre will also transfer from the NGH to the RVI in the summer of 2010, meaning that this highly specialised field of healthcare will soon be housed in superb facilities with direct access to the most advanced and powerful scanning and treatment techniques available today. Clinical director for neurosciences Anil Gholkar said: “Having the neurosciences centre located so close to the new emergency department means that patients admitted as emergencies with head injuries, brain haemorrhages or suspected strokes will be seen straight away.
“The new hospital will be equipped with the state-of-theart facilities for imaging and delivery of minimally invasive techniques.
“The integrated design of the new building and close proximity of services also means that our experts will work closely together to apply the very latest and best clinical practice.”
With an advanced neurovascular suite and leading edge imaging equipment, the neuroradiological experts have the ability to provide rapid, high quality vascular imaging with exceptional anatomical detail which means patients will benefit from earlier diagnosis and treatment leading to better clinical results.
Through the integrated des-igof the building and close proximity of services the neurosciences staff will have direct access to colleagues with expertise in closely related trauma specialties, in particular spinal specialists, maxillofacial surgeons and stroke physicians – all working closely together to share the very latest and best clinical practice.
Clear emergency access to the unit was a priority during the planning stages and this has led to the creation of a “blue light” route allowing direct access from Richardson Road via a specially designed flyover for ambulance and car transport.
Furthermore, patients who have suffered life-threatening injuries or a major illness need rapid transfer to the nearest centre with the specialist services they need.
Patients can be taken by helicopter to a helipad on the rooftop of the New Victoria Wing. From here there is direct access to the resuscitation room of the emergency department, where staff await their arrival, ensuring minimum delay in receiving the specialist care and treatment they need.
FACTFILE The Newcastle Hospitals offer more nationallyaccredited specialist services than any other group of hospitals in the UK – this means that whatever your need, we have world-renowned clinicians who have expertise in just about any condition or illness you can think of. Recognised for consistently delivering high-quality patient care, we have been named for the 9th year running as one of the top 40 performing hospitals in the country by independent benchmarking firm, CHKS, an achievement matched by only four other NHS service providers.
Our hospitals would not be such a success without the endless dedication of the people who deliver our service day to day
USA TODAY, June, 2009 by Kevin Allen
Goaltending
Pittsburgh Penguins
A Marc-Andre Fleury was sharp early to set the tone and made a big stop against Henrik Zetterberg. Made key saves in the third.
Detroit Red Wings
A Chris Osgood’s solid play kept the Red Wings in the game.
Offense
Pittsburgh Penguins
A- Third-liners came up with the key goals in this game.
Detroit Red Wings
B- Didn’t quit. Scored a goal to make it close in the third but needed more.
Defense
Pittsburgh Penguins
A Didn’t give the Red Wings much room or many good looks at the net.
Detroit Red Wings
B Gave up too many chances but had a good third period.
Special teams
Pittsburgh Penguins
A- Produced two…
Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)
Business Wire, Sept 13, 2007
LYON, France — Reportlinker.com announces that a new market research report related to the worldwide wound care industry is now available to its catalogue.
Wound Care, 3rd Edition, Vol. II: Burns
http://www.reportlinker.com/p058550/Burns-Products-Care- Market.html
(Due to its length, this URL may need to be copied/pasted into your Internet browser’s address field. Remove the extra space if one exists.)
The aging of the population and continued advances in biotechnology drive the multi-billion dollar wound care industry globally.
Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques.
The 3rd edition of this report details total manufacturers’ revenues, forecasts and developments for the following product categories:
* Anti-infectives
* Burn Injury Management, including:
* Wound Cleaners
* Debridement
* Silver Dressings
* Moist Dressings, including:
* Alginates
* Films
* Foams
* Hydrocolloids
* Hydrogels
* Biological Dressings, including:
* Artificial Skin
* Collagen
* Pressure Relief
* Miscellaneous Treatments
For each segment, the report includes the following:
* Current Market Size
* Historical Data (2001-2005)
* Revenue Forecasts (2007-2011)
* Review of major products
* Industry Developments
* Competitive Market Share
The information and analysis presented in this report are based on an extensive survey of senior management in the world wound care for burns industry.
Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals.
Key information from published literature was used to conduct interviews with over 27 industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry.
Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
All market data pertains to the U.S. market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2006. Historical data are provided for each of the years 2001 through 2011, and forecast data are provided for each of the years 2006 through 2011. Historical, base year, and forecast data are provided for each market segment
Business Wire, July 5, 2000
Business Editors
TORRANCE, Calif.–(BUSINESS WIRE)–July 5, 2000
This holiday season, music lovers on the go won’t need to carry a CD holder to enjoy hours of their favorite tunes. Casio Communications today announced the PZ-5000, a full-featured MP3 personal CD player, at a very affordable price of $159.99.
The conveniently sized unit plays MP3 files recorded on a CD-R as well as conventional audio CDs. The PZ-5000′s extended play function plays up to 160 MP3 music files — without the expense or space limitations of a CD changer. Users also receive a handy car kit, making the unit ideal for travel.
The PZ-5000 also features MP3-compatible Search/Play functions for locating specific tracks quickly and easily, giving users immediate access to their favorite songs. Searches are available alphabetically by the first letter of a song title, by “intro” — the first ten seconds of each song, or by “Directory Search”, a convenient and intuitive function that allows users to select titles via directories that are designated during the formatting of the MP3 files.
“Casio Communications would like to see MP3 capabilities become a standard feature in personal CD players,” said Mino Takahashi, director of Casio Communications’ sales/administration audio division. “We’re out to challenge the industry with both the features and price of the PZ-5000
Business Wire, April 3, 2006
DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c35109) has announced the addition of Chinese Markets For Dining Room and Kitchen Furniture to their offering.
This report examines China’s macroeconomic trends, investment environment, dining room & kitchen furniture industry structure and capacity, production and demand, market consumption trends, distribution channels and principal industry participants. Longterm forecasts for dining room & kitchen furniture production and demand are included. The report contains 60 tables and charts. Key producers are profiled. Top Chinese dining room & kitchen furniture producers are listed in the producer directory section.
Most primary and secondary research was done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, Chinese furniture associations including Chinese dining room & kitchen furniture associations, local governments’ light industry bureaus, furniture industry publications, and our in-house databases. Interviews were conducted with Chinese industry experts, university professors, and dining room & kitchen furniture producers in China.
Historical data include 1995, 2000 and 2005. Longterm development trends are projected to the years 2010 and 2015
Natural Health, April, 2007 by Adam Levey
Holistic Dermatologist
Dandruff is a reaction to Malassezia [furfur], a yeast that lives on the hair follicles. The condition can be aggravated by an overgrowth of yeast in the intestines or an insufficient amount of essential fatty acids in the diet.You can treat the flakes by killing the yeast with an antidandruff shampoo. Formulas that contain zinc work, as does Loprox, an antifungal, prescription-only shampoo. I also recommend eating more yogurt or probiotics and increasing your consumption of healthy oils, like fish oil
Film Ireland, May/Jun 2009
Fran
Shooting has completed on Fran for Setanta Sports. Created by Richard Conroy and Mark Hodkinson, who were responsible for the short film Up for Air, Fran is a mockumentary about an assistant manager of an amateur Leinster league soccer team.
The series is made up often 10-minute episodes. Two episodes will be broadcast every Saturday in May on Setanta Ireland and will mark the station’s first time to get involved in screen comedy/drama. The cast includes Darragh Humphreys as Fran and Robbie Byrne as Bobby.
Eimear O’Kane produced for Snowluke Pictures and the series was funded by BCI Sound & Vision and Setanta
USA TODAY, August, 2008 by Bruce Horovitz
SEATTLE — Starbucks is on the brink of rolling out a serious reinvention of its breakfast food.
Details of the chain’s long-anticipated move into better-for-you food — so hush-hush that it had its own code name, Morning Source — will be unveiled today. It comes as Starbucks’ U.S. stores are struggling with drops in traffic and comparable sales growth as many cash-strapped consumers hesitate to shell out $4 for their java fix.
The more nutrition-friendly food — fewer calories, more protein, fiber and fruit — will show up Sept.3 on the breakfast menu at most of the 11,570 locations in the U.S. and Canada
Market Wire, August, 2009
SunSi Energies Inc. (OTCBB: SSIE) announced
today that its wholly owned subsidiary, SunSi Energies Hong Kong Ltd, has
signed a definitive joint venture agreement (following the Letter of Intent
released in the June 9, 2009 news release) to form a Trichlorosilane (TCS)
production joint venture in Zibo, China.
As previously released, SunSi Energies Hong Kong Ltd will own 90% of a new
company specifically formed to own the assets, expertise and technology of
an existing Trichlorosilane production facility with a current production
capacity of 25,000 MT per year.
The new company, to be called Zibo Boayun Chemical Company Ltd, will
produce TCS, a chemical used in the production of polysilicon, an essential
raw material used during the production of solar cells for photovoltaic
(PV) panels that convert sunlight to electricity. TCS is considered the
first product in the solar PV value chain before polysilicon, and is also
the primary source of ultrapure silicon for the semiconductor industry.
This acquisition strategically positions SunSi as the first company with
focused operations specializing in TCS production to have their common
stock publicly traded in the U.S.
Under the Joint Venture agreement recently signed, all of the assets,
including permits, rights, land usage, as well as the entire labor force
and management team of the Chinese TCS producer will be transferred, upon
closing of the transaction, into the newly formed Joint Venture Company of
which SunSi Energies Hong Kong Ltd will own 90% of the equity. While, the
current name plate capacity of the facility is 25,000 metric tons of TCS
per year, SunSi has committed to double this over the next 12 months. While
this transaction is taking place, the TCS production facility continues its
normal activities.
“We are delighted to move forward with the Zibo team. They are well
respected as a TCS producer and we feel that we’ve teamed up with the best
TCS producer in China. Both teams share the same goals and we are proud of
the relationship we’ve built over the last 6 months. We can now focus on
expanding production at the current facility and focus on business outside
of China which is already coming our way,” said Mr. Michel G. Laporte,
President of SunSi Energies Inc.
About SunSi Energies Inc. (“SunSi”)
SunSi Energies Inc. aims to acquire and develop a portfolio of high quality
Trichlorosilane (TCS) producing facilities that are strategically located
and possess a potential for future growth and expansion. SunSi’s first
transaction has been launched in China through the acquisition of 90% of a
well-established Trichlorosilane facility. Relatively unknown, but
essential to the solar industry, Trichlorosilane is the main feedstock of
the solar industry, used in the production of polysilicon. With this
acquisition, it is believed that SunSi becomes the first and only “pure
play” public company in the world honed on the production of
Trichlorosilane. SunSi Energies Inc. is traded on the NASDAQ OTC Bulletin
Board under the ticker SSIE